JAMES TOPPER

Profile

First Name

: JAMES

Middle Name

:

Last Name

: TOPPER

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
CALISTOGA PHARMACEUTICALS INC
AARON COE, ROBERT LEE DOUGLAS, CAROL GALLAGHER, W. MICHAEL GALLATIN, W. MICHAEL GALLATIN, ANDREW GUGGENHIME, ED HURWITZ, EDWARD HURWITZ, RICHARD LIN, LANGDON MILLER, CLIFFORD STOCKS
DIRECTOR
INCLINE THERAPEUTICS, INC.
JIM GLASHEEN, JAMES GLASHEEN, PH.D., TERRY GOULD, ALAN LEVY, PH.D., THEODORE R. SCHROEDER, DAVID SOCKS, DAVID A. SOCKS, JAMES TOPPER, M.D., PH.D., JIM YOUNG, JAMES W. YOUNG, PH.D.
DIRECTOR
PORTOLA PHARMACEUTICALS INC
JEAN-JACQUES BIENAIME, JEFF BIRD, FARAH CHAMPSI, MARDI DIER, ALAN FRAZIER, NICHOLAS GALAKATOS, JEAN GEORGE, PAMELA GREEN, RUSSELL HIRSCH, CHARLES HOMCY, WILLIAM LIS, DAVID R. PHILLIPS, PEGGY PHILLIPS, HOLLINGS RENTON, HENRY WARD WOLFF
DIRECTOR
ATTEROCOR, INC.
THIERRY ABRIBAT, JEFFERY BRINZA, CAROL GALLAGHER, WILLIAM HARRINGTON, WILLIAM J. HARRINGTON, MARY LYNNE HEDLEY, JAMES HINDMAN, RAILI KERPPOLA, RAILI E. KERPPOLA, PHARIS MOHIDEEN, CAROLE NEUCHTERLEIN, JULIA OWENS, JULIA C. OWENS, ANDREW J. SCHWAB, CHRISTOPHER SEITER, RANDALL WHITCOMB
DIRECTOR
SEMNUR PHARMACEUTICALS, INC.
BRENT AHRENS, EDGAR ENGLEMAN, JAISIM SHAH, MAHENDRA G. SHAH
DIRECTOR
PRONAI THERAPEUTICS INC
CHARLES BISGAIER, ALBERT CHA, ROBERT FORGEY, JACK LUDERER, RICHARD MESSMAN, RICHARD MESSMANN, DONALD PARFET, DONALD R. PARFET, JOHN PUISIS, JOHN PUISUS, WENDI RODRIGUEZA, MINA SOOCH, MINA P. SOOCH, MINA PATEL SOOCH, PETER THOMPSON, ALVIN VITANGCOL
DIRECTOR
ALLENA PHARMACEUTICALS, INC.
AXEL BOLTE, LOUIS BRENNER, LOUIS BRENNER, M.D., ALLENE DIAZ, MARK FITZPATRICK, RICHARD D. KATZ, M.D., STEPHEN KRAUS, ALEXEY MARGOLIN, ANN C. MILLER, GINO SANTINI, ROBERT TEPPER
DIRECTOR
CHANRX CORP.
ROBERT BALTERA, JR., ARTHUR BROWN, JEREL DAVIS, HOWARD DITTRICH, BRIAN FARMER, JIM GRAHAM, RAJESH KHOSLA, KEVIN LALANDE
DIRECTOR
ANAPTYSBIO INC
TIBA AYNECHI, CAROL GALLAGHER, ROBERT HOFFMAN, KEVIN KINSELLA, MARCO LONDEI, HEATH LUKATCH, HEATHE LUKATCH, NICHOLAS LYDON, NICK LYDON, J. LEIGHTON READ, HOLLINGS RENTON, JOHN SCHMID, THOMAS SMART, HAMZA SURIA, JAMES N. TOPPER
DIRECTOR
LAGUNA PHARMACEUTICALS, INC.
ROBERT BALTERA, JR., ARTHUR BROWN, JEREL DAVIS, HOWARD DITTRICH, BRIAN FARMER, JIM GRAHAM, RAJESH KHOSLA, KEVIN LALANDE
DIRECTOR
ALPINE IMMUNE SCIENCES, INC.
DR. MITCHELL H GOLD, MITCHELL H. GOLD, MICHAEL KORNACKER, DAVID MILLER, STANFORD PANG, J. PAUL RICKEY, RYAN SWANSON, PETER THOMPSON, JAY VENKATESAN
DIRECTOR
MERGANSER BIOTECH, INC.
JEFFREY BIRD, COLIN GODDARD, MARKUS GOEBEL, BRIAN MACDONALD, REMY SUKHIJA
DIRECTOR
ALCRESTA, INC.
TODD CREECH, STEVE DUBIN, ERIC FIRST, ROBERT GALLOTTO, JAMES GAMGORT, GARHENG KONG, ANASTASIOS KONIDARIS, TASOS KONIDARIS, STEPHEN KRAUS, STEPHEN KRAUSS, JEREMY LACK, ALEXEY MARGOLIN, DANIEL ORLANDO, MARTIN PAZ, WILLIAM SCHEINLER, DANIEL TASSE
DIRECTOR
ALCRESTA THERAPEUTICS, INC.
TODD CREECH, STEVE DUBIN, ERIC FIRST, ROBERT GALLOTTO, JAMES GAMGORT, GARHENG KONG, ANASTASIOS KONIDARIS, TASOS KONIDARIS, STEPHEN KRAUS, STEPHEN KRAUSS, JEREMY LACK, ALEXEY MARGOLIN, DANIEL ORLANDO, MARTIN PAZ, WILLIAM SCHEINLER, DANIEL TASSE
DIRECTOR
MILLENDO THERAPEUTICS, INC.
THIERRY ABRIBAT, JEFFERY BRINZA, CAROL GALLAGHER, WILLIAM HARRINGTON, WILLIAM J. HARRINGTON, MARY LYNNE HEDLEY, JAMES HINDMAN, RAILI KERPPOLA, RAILI E. KERPPOLA, PHARIS MOHIDEEN, CAROLE NEUCHTERLEIN, JULIA OWENS, JULIA C. OWENS, ANDREW J. SCHWAB, CHRISTOPHER SEITER, RANDALL WHITCOMB
DIRECTOR
APTINYX INC.
PATRICK ENRIGHT, PATRICK G. ENRIGHT, WILBUR H. GANTZ III, TERRY P. GOULD, ASHISH KHANNA, ANDREW D. KIDD, ADAM M. KOPPEL, TORSTEN M. MADSEN, JOSEPH R. MOSKAL, LIAM RATCLIFFE, NORBERT G. RIEDEL, JAMES N. TOPPER
DIRECTOR
ALPINE IMMUNE SCIENCES, INC.
ROBERT CONWAY, HOWARD FURST, MITCHELL GOLD, ZELANNA GOLDBERG, NATASHA HERNDAY, JONATHAN LEFF, MARK JAMES LITTON, EVAN LOH, JOSEPH LOSCALZO, JOHN MOORE, CHRISTOPHER PEETZ, STANFORD PENG, JAMES PAUL RICKEY, PAUL SEKHRI, TOM SOKOLOWSKI, PETER THOMPSON, JAY VENKATESAN, CUI XIANGMIN
DIRECTOR
AMUNIX PHARMACEUTICALS, INC.
JAMES BRUSH, RICHARD HEYMAN, DAVID HIRSCH, TRISHA MILLICAN, VOLKER SCHELLENBERGER, OTELLO STAMPACCHIA, ANGIE YOU
DIRECTOR
ENLAZA THERAPEUTICS, INC.
SHELLEY CHU, SERGIO DURON, JAY LICHTER, SANFORD MADIGAN, MARCOS MILLA, TIGHE REARDON, STEPHEN SQUINTO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-29 
2024-08-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-05 
2022-11-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-12 
2022-10-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
2022-10-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-04 
2021-09-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-17 
2021-08-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-30 
2021-06-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-10 
2021-03-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-12 
2021-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-26 
2021-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-01-07 
2020-08-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-28 
2020-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-06-17 
2020-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-28 
2019-01-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-01-18 
2017-12-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-12-19 
2017-12-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-15 
2017-09-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-15 
2017-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-24 
2016-10-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-22 
2016-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-10 
2016-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-22 
2016-04-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-13 
2016-01-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-18 
2015-12-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-25 
2015-07-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-15 
2015-07-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-07-13 
2015-02-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-03 
2014-11-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-29 
2014-05-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-17 
2013-08-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-06 
2013-02-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-25 
2012-09-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-25 
2012-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-25 
2012-04-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-04-17 
2011-12-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-07 
2011-12-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-18 
2010-12-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-29 
2010-07-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-29 
2010-01-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-12-23 
2009-05-14
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-05-01 
2009-03-17
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-03-13